Edwards Lifesciences
在场
是其中之一......
Edwards Lifesciences 是一家在股票代码 EW (US) 下上市的公司。
Edwards Lifesciences 在 2 个国家有直接业务。
他们在：
高管
查看带有其 32 名主要高管的组织结构图
Edwards Lifesciences 搜索最多的简介
- Bernard Zovighian, President and Chief Executive Officer
- Kieran Gallahue, Director
- Leslie Heisz, Director
高管在Edwards Lifesciences变化
- Michael Mussallem, Chairman of the Board, 将于 20245月7 退休 (新闻发布的2024三月29号).
- Nicholas Valeriani 曾任 Director, 将于 20245月7 升职为 Chairman of the Board (新闻发布的2024三月29号).
创建提醒
跟踪 Edwards Lifesciences 的高管变动
医疗设备
Edwards Lifesciences 拥有 985 家竞争者，其中包括 Philips (荷兰)、Medtronic (爱尔兰岛) 和 Thermo Fisher Scientific (美国(美洲))。
Popular M&A news in 医疗设备
- Medigus将在Apr 12, 2024将其名称改为Xylo Technologies。 (公布2024四月12号).
- Johnson & Johnson has announced the acquisition of Shockwave Medical (公布2024四月6号).
- Carlsmed 刚刚宣布为 52 筹款数百万美元。 (公布2024三月22号).
医疗设备 行业的其他推荐联系人
消息
Edwards Lifesciences 的最新新闻稿
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
- Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
- Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Page Not Found
- Edwards Lifesciences Corp - EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE
- TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION
- CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION
- FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE
- EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS
- EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023
- View more press releases Close
通过电子邮件
